Retour aux projets

18543.1 PFLS-LS

Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase

Résumé

Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase

Textes supplémentaires

Abstract

Addex has identified novel small molecules, which are positive allosteric modulators of the neuroprotective receptor TrkB. These compounds, which have a major potential for the treatment of neurodegenerative diseases (e.g. Huntington¿s disease and amyotrophic lateral sclerosis) will be profiled in unique assays developed by the Krause group at University of Geneva. The results obtained will enable the prioritization of compounds for later stages of preclinical development.

Participants

Tim Dyer

Wirtschaftspartner

Tim.Dyer@addexpharma.com

Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH

Karl-Heinz Krause

Kontaktperson

karl-heinz.krause@unige.ch

Université de Genève Karl-Heinz Krause Rue Michel Servet 1 1211 Genève GE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2016-12-31
Date de fin
2019-03-31
Coûts totaux approuvés
CHF 440762.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%